Submitted by Anonymous (not verified) on 30 August 2024 - 10:45
Human medicines European public assessment report (EPAR): Piasky, Crovalimab, Date of authorisation: 22/08/2024, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Piasky, Crovalimab, Date of authorisation: 22/08/2024, Status: Authorised